HuagongsheHuagongshe Chemistry Print Report · For research reference only
Posaconazole → Dibenzyl ether
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Posaconazole | HCID 468595 | — |
| Reactant | Posaconazole Impurity 3 | HCID 78577436 | — |
| Product | Dibenzyl ether | HCID 7657 | — |
| Product | Posaconazole | HCID 468595 | — |
Reaction Steps
U.S. Pat. No. 5,625,064 discloses a process for the preparation of posaconazole which involves the condensation of 1-((2S,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one with (−)-(5R-cis)-5-(2,4-difluorophenyl)-5-[1,2,4]triazol-1-ylmethyl-tetrahydro-3-furanmethylester derivative in the presence of a base to give benzyl ether of posaconazole which is then deprotected either with palladium on carbon in the presence of formic acid or aqueous hydrobromic acid to form posaconazole.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09102664B2 |
| Source dataset | uspto-grants-2015_08 |
| ORD ID | ord-f3f265dc173646b0a109c8dbeffb9640 |
| Source note | uspto-grants-2015_08 |